Published in Semin Liver Dis on February 01, 2005
Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis (2008) 1.78
Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. J Infect Dis (2008) 1.30
Current progress in development of hepatitis C virus vaccines. Nat Med (2013) 1.28
Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients. Crit Care (2009) 1.28
Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. J Infect Dis (2012) 1.24
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World J Gastroenterol (2014) 0.98
Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1. Virol J (2011) 0.93
Prospective follow-up of patients with acute hepatitis C virus infection in Brazil. Clin Infect Dis (2010) 0.92
Immune responses during acute and chronic infection with hepatitis C virus. Clin Immunol (2008) 0.92
Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study. PLoS One (2015) 0.87
Clinical characteristics, spontaneous clearance and treatment outcome of acute hepatitis C: a single tertiary center experience. Saudi J Gastroenterol (2013) 0.84
Acute hepatitis C outbreak among HIV-infected men, Madrid, Spain. Emerg Infect Dis (2011) 0.84
Antibody dynamics and spontaneous viral clearance in patients with acute hepatitis C infection in Rio de Janeiro, Brazil. BMC Infect Dis (2011) 0.80
Distinct features in natural history and outcomes of acute hepatitis C. J Clin Gastroenterol (2015) 0.76
Acute hepatitis C: prospects and challenges. World J Gastroenterol (2007) 0.75
Hepatitis C virus infection--pathobiology and implications for new therapeutic options. Dig Dis Sci (2007) 0.75
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet (2013) 6.19
Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol (2002) 4.56
The liver as an immunological organ. Hepatology (2006) 3.86
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology (2006) 3.44
Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology (2004) 2.64
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology (2009) 2.41
Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology (2011) 2.33
Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol (2002) 2.31
B cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naïve B cell apoptosis. Hepatology (2012) 2.05
Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol (2003) 1.93
The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity. J Virol (2003) 1.90
Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions. Blood (2004) 1.77
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J Clin Invest (2006) 1.66
Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med (2013) 1.64
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C. Gut (2013) 1.63
Sequence analysis of hepatitis C virus from patients with relapse after a sustained virological response: relapse or reinfection? J Infect Dis (2013) 1.61
Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest (2004) 1.58
Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology (2008) 1.57
Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection. Hepatology (2014) 1.52
Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest (2008) 1.52
IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection. Hepatology (2012) 1.44
Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology (2009) 1.40
Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses. Gastroenterology (2010) 1.32
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients. Hepatology (2011) 1.32
Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. J Infect Dis (2008) 1.30
Hepatitis C virus infection: when silence is deception. Trends Immunol (2003) 1.29
Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood (2006) 1.25
Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. J Infect Dis (2012) 1.24
Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection. J Hepatol (2011) 1.18
Cellular immune responses to the hepatitis B virus polymerase. J Immunol (2004) 1.15
Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates. J Virol (2004) 1.13
Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus. Gastroenterology (2012) 1.12
Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C. Gastroenterology (2011) 1.09
Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults. Vaccine (2005) 1.05
Identification of novel chimpanzee MHC class I and II alleles using an improved sequence-based typing strategy. Hum Immunol (2006) 1.04
Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity. Immunity (2004) 0.99
The kinetics of hepatitis C virus-specific CD8 T-cell responses in the blood mirror those in the liver in acute hepatitis C virus infection. J Virol (2008) 0.98
Hepatitis C vaccines: Inducing and challenging memory T cells. Hepatology (2006) 0.97
Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection. Hepatology (2013) 0.96
High levels of subgenomic HCV plasma RNA in immunosilent infections. Virology (2007) 0.93
The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection. J Virol (2013) 0.93
Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies. J Virol (2002) 0.92
Liver-directed gamma interferon gene delivery in chronic hepatitis C. J Virol (2005) 0.89
Occupational exposure to hepatitis C virus: early T-cell responses in the absence of seroconversion in a longitudinal cohort study. J Infect Dis (2013) 0.88
The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling. Transfusion (2012) 0.85
The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity. Gastroenterology (2013) 0.85
Proteasome activator and antigen-processing aminopeptidases are regulated by virus-induced type I interferon in the hepatitis C virus-infected liver. J Interferon Cytokine Res (2007) 0.85
More rare birds, and the occasional swan. Gastroenterology (2009) 0.83
Trace amounts of sporadically reappearing HCV RNA can cause infection. J Clin Invest (2014) 0.82
Taking the brake off T cells in chronic viral infection. Nat Med (2006) 0.82
Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. Gastroenterology (2008) 0.81
The accelerating pace of HCV research: a summary of the 15th International Symposium on Hepatitis C Virus And Related Viruses. Gastroenterology (2008) 0.79
Acute hepatitis C. Gastroenterology (2009) 0.79
Chronic hepatitis B and hepatocarcinogenesis: does prevention of "collateral damage" bring the cure? Hepatology (2003) 0.78
Ethnicity and hepatitis C virus infection. Clin Gastroenterol Hepatol (2004) 0.78
Dendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge. Vaccine (2010) 0.76
Chronic HCV infection and the clonality of intrahepatic T cells. J Hepatol (2003) 0.76
Determination of hepatitis B virus-specific CD8+ T-cell activity in the liver. Methods Mol Med (2004) 0.76
Reply: b-cell frequency in HCV-related mixed cryoglobulinemia. Hepatology (2013) 0.75
Hepatitis C virus and the threshold of natural killer cell inhibition. Hepatology (2005) 0.75
Analysis of HCV-specific T cells by flow cytometry. Methods Mol Biol (2009) 0.75
Determination of HCV-specific T-cell activity. Methods Mol Biol (2009) 0.75